Nurocor Partners With Intilaris to Accelerate Clinical Trials

FRANKFURT, Germany, November 5, 2018 (Newswire.com) - Nurocor announced today that it has entered into a partnership with intilaris LifeSciences GmbH. Nurocor is the leading Clinical Metadata Repository provider with a mission to bring order to clinical data. intilaris LifeSciences is a consulting and services company optimizing drug development through structured information and content-driven processes for the pharmaceutical industry. The companies will collaborate to create efficiency by accelerating the use of standards in the planning stage of clinical trials. This enables substantial efficiency gains and cost savings during the conduct of clinical trials.

Nurocor’s mission is to bring order to clinical data. The world of clinical data is becoming increasingly complex. Nurocor believes that through the disciplined management of data standards and semantics, customers can control this complexity, and turn it into a business advantage.

We are pleased to partner with intilaris to help customers optimize clinical trial processes beginning at the planning stage. Combining the Nurocor MDR with intilaris deep industry expertise and established structured data and content-driven processes, we will be able to help customers accelerate the use of standards in the planning stage of clinical trials to bring new drugs to market more quickly and at lower cost.

Alex Lazar, Nurocor President & Founder

Nurocor and intilaris will work together to deliver solutions that combine intilaris’ expertise and standardized processes with the Nurocor MDR to automate many aspects of the planning stage of Clinical Trials. These solutions will help the pharmaceutical industry bring new drugs to market more quickly and at lower costs.

“We are pleased to partner with intilaris to help customers optimize clinical trial processes beginning at the planning stage,” said Alex Lazar, Nurocor President and Founder. “Combining the Nurocor MDR with intilaris deep industry expertise and established structured data and content-driven processes, we will be able to help customers accelerate the use of standards in the planning stage of clinical trials to bring new drugs to market more quickly and at lower cost.”

intilaris is a consulting and service company that provides expertise in:

• Structured and standardized drug development processes
• Alignment and design of exploratory and confirmatory clinical studies
• Compliance with applicable quality and regulatory requirements
• Critical path to regulatory approval

“We are looking forward to helping our customers automate their clinical trial processes using the Nurocor MDR,” said Thorsten Friedel, intilaris Managing Director. “Automating the planning of clinical trials with structured data and content-driven processes will help our customers realize significant cost and time savings.”

About intilaris

intilaris LifeSciences GmbH is a Swiss consulting and service company optimizing drug development through structured information and content-driven processes for the pharmaceutical industry. intilaris implements, introduces, and delivers content and data-driven processes, leading to higher productivity in drug development.

About Nurocor

Nurocor helps companies like Amgen, inventive Health, Novartis, Pfizer, and Roche bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly. Created by a team combining deep industry expertise with a proven ability to bring technology solutions to market, Nurocor MDR is the industry-leading standards metadata repository enabling the seamless interchange of data between Electronic Data Capture and Clinical Data Management systems and regulatory agencies.

Source: Nurocor